Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ViiV Healthcare
Age
18–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Participant must be ≥18 years of age, at the time of signing the informed consent.
HIV negative at screening. Type of HIV-1 test is per standard of care.
No prior history of receiving oral CAB or CAB LA injections.
PrEP provider deems CAB PrEP use to be appropriate per the applicable CAB PrEP prescribing information prior to enrollment in the study.
Female at birth or self-identified Transgender Female.
Self-identified as African American/Black
Capable of giving signed informed consent
You may not be if
HIV indeterminate or positive test result during screening.
A participant of concurrent interventional clinical or implementation science study at any time during the study.
Cis-gender or Transgender male
Clareo Health | A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories
